drugset / Trial / NCT05237297
Study to Evaluate Pharmacokinetic Drug Interactions and Safety of Naproxen, Aceclofenac, Celecoxib and Ilaprazole
RandomizedCrossoverOpen-labelTreatment
Summary
This study evaluate the pharmacokinetic drug interactions and safety after co-administration of ilaprazole and NSAID in healthy adults.
Timeline
- Start
- 2022-02-17
- Primary completion
- 2022-07-13
- Completion
- 2022-07-27
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Aceclofenac | Small molecule | 100 mg | — |
| Comparator | Celecoxib | Other / unclassified | 200 mg | — |
| Comparator | Ilaprazole | Small molecule | 10 mg | — |
| Comparator | Naproxen | Small molecule | 500 mg | — |
Indications
No indication recorded.